CompletedNCT01164878

Cholestasis in Extreme Low Birth Weight Infants (ELBW)

Studying Parenteral nutrition-associated cholestasis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Medical University of Vienna
Principal Investigator: Nadja Haiden, MD
Medical University Vienna
Enrollment: 122 target
Eligibility: All sexes
Timeline: 2010 – 2010

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01164878 on ClinicalTrials.gov

Other trials for Parenteral nutrition-associated cholestasis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT06274788
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Fresenius Kabi
RECRUITINGPHASE4NCT06049680
Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients
Fresenius Kabi

See all trials for Parenteral nutrition-associated cholestasis →

← Back to all trials